
AroCell Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from AroCell
Access all reports
AroCell AB is a Swedish diagnostics company that develops and markets blood and urine sample tests primarily for monitoring cancer, particularly breast, prostate, and bladder cancers. Its main product is the AroCell TK 210 ELISA, an immunoassay kit that measures Thymidine Kinase 1 protein levels in blood samples, helping to assess cell proliferation in cancer patients. Another key product, UBC Rapid, is used for diagnosing and monitoring bladder cancer. AroCell is headquartered in Stockholm, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
AROC
Country
🇸🇪 Sweden